Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nelson L. Michael"'
Autor:
Saranya Sridhar, Arnel Joaquin, Matthew I Bonaparte, Agustin Bueso, Anne-Laure Chabanon, Aiying Chen, Roman M Chicz, David Diemert, Brandon J Essink, Bo Fu, Nicole A Grunenberg, Helene Janosczyk, Michael C Keefer, Doris M Rivera M, Ya Meng, Nelson L Michael, Sonal S Munsiff, Onyema Ogbuagu, Vanessa N Raabe, Randall Severance, Enrique Rivas, Natalya Romanyak, Nadine G Rouphael, Lode Schuerman, Lawrence D Sher, Stephen R Walsh, Judith White, Dalia von Barbier, Guy de Bruyn, Richard Canter, Marie-Helene Grillet, Maryam Keshtkar-Jahromi, Marguerite Koutsoukos, Denise Lopez, Roger Masotti, Sandra Mendoza, Catherine Moreau, Maria Angeles Ceregido, Shelly Ramirez, Ansoyta Said, Fernanda Tavares-Da-Silva, Jiayuan Shi, Tina Tong, John Treanor, Carlos A Diazgranados, Stephen Savarino
Publikováno v:
The Lancet. Infectious Diseases
Background We evaluated our SARS-CoV-2 prefusion spike recombinant protein vaccine (CoV2 preS dTM) with different adjuvants, unadjuvanted, and in a one-injection and two-injection dosing schedule in a previous phase 1–2 study. Based on interim resu
Autor:
Jessica L Ansel, Dan H. Barouch, Kayvon Modjarrad, Katherine E. Yanosick, Lauren Peter, Edward T. Moseley, Rafael De La Barrera, Tatenda Makoni, Michael S. Seaman, Peter Dawson, Rachel Fogel, Joseph P. Nkolola, Kathryn E. Stephenson, Stephen R. Walsh, Andrew J. Hale, Diane G. Kanjilal, Kate Jaegle, Nelson L. Michael, Stephen J. Thomas, Connor Bradshaw, Abishek Chandrashekar, Jason Thompson, Kenneth H. Eckels, Erica N. Borducchi, Anna Tyler, Chen S. Tan
Publikováno v:
Lancet Infect Dis
Summary Background The development of an effective vaccine against Zika virus remains a public health priority. A Zika purified inactivated virus (ZPIV) vaccine candidate has been shown to protect animals against Zika virus challenge and to be well t
Autor:
Megan C. Wise, Kristopher Paolino, Deborah Kane, Claude Lamarre, Faraz I. Zaidi, Paul T. Scott, Ajay P. Parikh, Stephen J. Thomas, Young K. Park, Scott White, Sagar B. Kudchodkar, David B. Weiner, Amy R. Castellano, Elizabeth K. Duperret, Trina Racine, Myoung Don Oh, Merlin L. Robb, Hyeree Choi, Kristin Mills, Mark L. Bagarazzi, Jeanine M. May, Joel N. Maslow, Janice Darden, Emma L. Reuschel, Moonsup Jeong, Celine Remigio, Kayvon Modjarrad, Karuppiah Muthumani, Ami Patel, Kevin Kim, Nelson L. Michael, Jean D. Boyer, Hyo Jin Lee, Gary P. Kobinger, Christine C. Roberts
Publikováno v:
The Lancet. Infectious Diseases
Summary Background Middle East respiratory syndrome (MERS) coronavirus causes a highly fatal lower-respiratory tract infection. There are as yet no licensed MERS vaccines or therapeutics. This study (WRAIR-2274) assessed the safety, tolerability, and
Autor:
Alison Taylor, Gene G. Olinger, Hannah Kibuuka, Michael A. Eller, Anna N. Honko, Salim Wakabi, Danielle V Clark, Merlin L. Robb, Lisa E. Hensley, Leigh Anne Eller, Luswa Lukwago, Matthew J. Hepburn, Nelson L. Michael, Monica Millard, Randal J. Schoepp
Publikováno v:
The Lancet Infectious Diseases. 15:905-912
The limited data available for long-term Ebola virus disease health outcomes suggest that sequelae persist for longer than 1 year after infection. The magnitude of the present outbreak in west Africa necessitates a more complete understanding of the
Autor:
Merlin L. Robb, Nelson L. Michael
Publikováno v:
The Lancet Infectious Diseases. 14:361-362